Polywin(Shanghai) Pharmaceutical Technology Co., Ltd.(hereinafter referred to as "Polywin") is a new type of comprehensive service platform established by the strategic alliance and joint investment of Shanghai Yunhong Pharmaceutical Excipients Co.,Ltd. and Shanghai Polymer Pharmaceutical&Excipient Co.,Ltd.
Polywin achieves deep integration of core strengths from both parties: leveraging Yunhong Excipients 'mature market network, comprehensive supply chain management system, and extensive industry client base exceeding 3,000 enterprises, while combining Pulimembrane's leading R&D innovation capabilities and lean production standards, thereby realizing resource complementarity and synergistic efficiency enhancement.
The business covers a diversified product portfolio including domestically produced and imported pharmaceutical excipients, medical aesthetic raw materials and technical services, film-coating premixes, as well as food and health supplement ingredients and additives. It provides one-stop professional services such as product registration, technical consultation, customized production, import/export agency, and cold chain logistics.
Polywin inherits the scientific research genes of Pulimembrane from the China Pharmaceutical Industry Research Institute, leveraging national-level research platforms, multiple invention patents, and industry-leading technologies such as the fourth-generation coating system. A professional R&D team provides customized solutions for clients, ranging from excipient screening and formulation design to process optimization, committed to creating exceptional value for the global pharmaceutical and healthcare industries and striving to become a trusted benchmark service provider and partner in the industry.
